AMGROS I/S has floated a tender for Information on Expected Conclusion of Commissioning Agreement for the Drug Fruzaqla (Fruquintinib). The project location is Denmark and the tender is closing on 11 Jul 2025. The tender notice number is -, while the TOT Ref Number is 104035937.
Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.
Procurement Summary
Country : Denmark
Summary : Information on Expected Conclusion of Commissioning Agreement for the Drug Fruzaqla (Fruquintinib)
Sign in with Google